Similarly, there was a nonsignificant trend from the second to fourth quartile in terms of increasing odds for low GS [Q2: OR 1.72 (95% CI 0.31, 1.69); Q3: OR 1.14 (95% CI 1.54, 2.52),; Q4: OR 1.48 (0.73, 2.99)] compared to the first SAF quartile.
← all excerpts
Skin Autofluorescence, a Noninvasive Biomarker for Advanced Glycation End-products, Is Associated With Sarcopenia.
1
—
—